Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 3/20 | 0.48 |
| ▸ | ITGA2B | P08514 | 3/20 | 0.48 |
| ▸ | PTPN11 | Q06124 | 2/20 | 0.42 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.40 |
| ▸ | TPH1 | P17752 | 7/20 | 0.39 |
| ▸ | PPARG | P37231 | 3/20 | 0.39 |
| ▸ | PPARA | Q07869 | 3/20 | 0.39 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.38 |
| ▸ | PPARD | Q03181 | 2/20 | 0.37 |
| ▸ | P2RY10 | O00398 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL25310774 | 0.99 | ITGB3 (0.47) | ITGB3ITGA2BPTPN11SRD5A2TPH1 | |
| Hydrochloric Acid SCHEMBL25310769 | 0.99 | ITGB3 (0.47) | ITGB3ITGA2BPTPN11SRD5A2TPH1 | |
| SCHEMBL30520789 | 0.85 | FFAR1 (0.49) | PTPN11PPARG | |
| SCHEMBL26262105 | 0.84 | PTPN11 (0.43) | PTPN11SRD5A2 | |
| SCHEMBL1999882 | 0.82 | SRD5A2 (0.51) | ITGB3ITGA2BSRD5A2TPH1PPARG | |
| SCHEMBL25260484 | 0.82 | ITGB3 (0.54) | ITGB3ITGA2BPTPN1 | |
| SCHEMBL25311934 | 0.82 | ITGB3 (0.54) | ITGB3ITGA2BPTPN1 | |
| SCHEMBL26263800 | 0.81 | ABCG2 (0.39) | PTPN11SRD5A2PPARGPPARAPPARD | |
| SCHEMBL31111350 | 0.81 | PTPN11 (0.39) | ITGB3ITGA2BPTPN11SRD5A2PTPN1 | |
| SCHEMBL26284279 | 0.80 | ITGB1 (0.36) | PTPN11PTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4673424-A1 | LIQUID PHASE PEPTIDE SUPPORT SYNTHESIS OF PEPTIDES AND PEPTIDOMIMETICS | Regeneron Pharmaceuticals, Inc. (US) | 2026-01-07 | — | — | EP | disclosed |
| WO-2024182268-A1 | LIQUID PHASE PEPTIDE SUPPORT SYNTHESIS OF PEPTIDES AND PEPTIDOMIMETICS | REGENERON PHARMACEUTICALS, INC. (US) | 2024-09-06 | — | — | WO | disclosed |